This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Fujifilm Corporation, Mochida Pharmaceutical Co., Ltd.. Active years: 1993-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (1993)
- Minato-ku, JP (2015 - 2018)
Company Filing History:
Years Active: 1993-2018
Title: The Innovations of Sumio Sugano
Introduction
Sumio Sugano is a notable inventor based in Minato-ku, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to his name, Sugano's work has the potential to impact the diagnosis and treatment of various carcinomas and necrosis-related conditions.
Latest Patents
One of Sugano's latest patents is a monoclonal antibody against the necrosis marker PRDX4. The problem addressed by this invention is the need for a biomarker that shows high specificity for effective detection and diagnosis of lesions related to various carcinomas and necrosis. The means of this invention includes a monoclonal antibody consisting of a specific amino acid sequence or a variant that maintains the same function and activity.
Another significant patent is a monoclonal antibody against the necrosis marker ERP29. Similar to the previous patent, this invention aims to provide a highly specific biomarker for the detection and diagnosis of lesions relevant to carcinomas and necrosis. The means of this invention also involves a monoclonal antibody with a defined amino acid sequence or a variant that shares a high degree of homology.
Career Highlights
Throughout his career, Sumio Sugano has worked with prominent companies such as Fujifilm Corporation and Mochida Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.
Collaborations
Some of Sugano's notable coworkers include Yukari Kanzaki and Tsuneo Saga. Their collaboration has likely played a role in advancing the research and development of innovative solutions in biotechnology.
Conclusion
Sumio Sugano's contributions to the field of biotechnology through his patents on monoclonal antibodies demonstrate his commitment to advancing medical diagnostics. His work continues to pave the way for innovative solutions in the detection and treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile